Revive & Restore, Sausalito, California, United States of America.
Wilson Sonsini Goodrich & Rosati, San Francisco, California, United States of America.
PLoS Biol. 2018 Oct 12;16(10):e2006607. doi: 10.1371/journal.pbio.2006607. eCollection 2018 Oct.
Horseshoe crabs have been integral to the safe production of vaccines and injectable medications for the past 40 years. The bleeding of live horseshoe crabs, a process that leaves thousands dead annually, is an ecologically unsustainable practice for all four species of horseshoe crab and the shorebirds that rely on their eggs as a primary food source during spring migration. Populations of both horseshoe crabs and shorebirds are in decline. This study confirms the efficacy of recombinant Factor C (rFC), a synthetic alternative that eliminates the need for animal products in endotoxin detection. Furthermore, our findings confirm that the biomedical industry can achieve a 90% reduction in the use of reagents derived from horseshoe crabs by using the synthetic alternative for the testing of water and other common materials used in the manufacturing process. This represents an extraordinary opportunity for the biomedical and pharmaceutical industries to significantly contribute to the conservation of horseshoe crabs and the birds that depend on them.
马蹄蟹在过去 40 年中一直是疫苗和注射类药物安全生产的关键。抽取活马蹄蟹的血液(每年有数千只马蹄蟹因此死亡),对这四种马蹄蟹以及春季迁徙期间依赖其卵作为主要食物来源的滨鸟来说,都是一种不可持续的生态做法。马蹄蟹和滨鸟的数量都在减少。本研究证实了重组因子 C(rFC)的功效,rFC 是一种合成替代品,可以在检测内毒素时消除对动物产品的需求。此外,我们的研究结果证实,生物医学行业可以通过使用这种合成替代品来检测水和制造过程中常用的其他常见材料,从而将试剂对马蹄蟹的使用量减少 90%。这为生物医学和制药行业提供了一个绝佳的机会,可以为保护马蹄蟹和依赖它们的鸟类做出重大贡献。